ShedRx and Skinny Rx Semaglutide: Side-by-Side Review

For the broader cluster context, see the compounded semaglutide provider comparison hub.
Author: HealthRX Editorial Team Medically reviewed by: Dr. Mark Halpern, MD (Internal Medicine, Obesity Medicine) Last clinical review: May 2026
Compounded semaglutide is not FDA-approved. This article is patient education and does not replace consultation with a licensed clinician.
Rachel, 38, in Tucson, spent a Saturday morning with eight browser tabs open, toggling between ShedRx and Skinny Rx checkout pages. "The pricing looked almost identical, the websites basically said the same things, and I still couldn't figure out which one I was supposed to pick," she told us. She'd been referred to both by friends in the same Facebook group. Her A1C was 5.9, her BMI was 34, and she wanted to start compounded semaglutide without locking herself into anything she couldn't cancel. She's not alone. These two providers occupy nearly the same niche, and patients shopping one are almost always shopping the other.
That's why this review exists: to lay the actual differences on the table, because the marketing pages won't do it for you.
This comparison fits inside the broader best compounded semaglutide telehealth providers comparison, which is part of the compounded semaglutide pillar guide.
The Quick Version: Nearly Twins, Not Quite Identical
Both ShedRx and Skinny Rx are asynchronous-first telehealth platforms offering compounded semaglutide at flat-rate monthly prices through 503A pharmacy partners. Both have rapid onboarding, broad state coverage, and questionnaire-based intake reviewed by a licensed clinician. Neither has been the subject of an FDA warning letter on its compounded GLP-1 program, and neither has been named as a defendant in the Novo Nordisk civil litigation alleging "inauthentic API" sourcing, based on public court records reviewed in early 2026.
The real differences come down to pricing structure, commitment terms, and a few operational details most people don't think to ask about until they're already enrolled.
ShedRx: What You're Actually Getting
ShedRx runs two pricing tracks: $249 per month if you commit to six months, or $279 per month on a month-to-month basis. The flat-rate structure means your price doesn't climb as your dose escalates, which matters because most patients titrate up over the first three to four months.
The medication ships from 503A pharmacy partners. The 2026 formulation, consistent with post-shortage compounding practice, is typically a personalization preparation that satisfies the 503A clinical-need standard. (More on what that means in the regulatory section below.)
Clinician interaction is asynchronous-first. You fill out a questionnaire, a licensed clinician in your state reviews it, and communication flows through the platform. Video visits are available for some plans on request, but they're not the default. ShedRx operates in roughly 47 states.
Skinny Rx: What You're Actually Getting
Skinny Rx prices compounded semaglutide at $269 to $299 per month, depending on which plan tier you select and whether you add supplemental services. There's no discounted multi-month commitment in the same form as ShedRx's six-month rate. You're month-to-month across all tiers.
Like ShedRx, Skinny Rx uses 503A pharmacy partners and runs an asynchronous-first clinical model. State coverage is similarly broad. LegitScript certification status for Skinny Rx should be verified directly on the LegitScript registry at the time you're evaluating, since certification status for smaller providers in this category does change.
Where the Money Math Actually Lands
Here's the thing about pricing in this category: the differences look small on a per-month basis but compound quickly. A patient using ShedRx's six-month rate saves $360 over six months compared to Skinny Rx's higher tier ($299). That's not nothing. But if you bail after three months, ShedRx's commitment structure could cost you more than Skinny Rx's flexibility would have.
For context, here's where both land against the broader market:
- HealthRX: $179.99 to $279.99 flat-rate
- Hims (annual): $199 effective
- ShedRx (6-month commitment): $249
- Skinny Rx (lower tier): $269
- ShedRx (month-to-month): $279
- Mochi Health (all-in): ~$279
- Skinny Rx (higher tier): $299
- Hims (monthly): $299
- Eden: $296
- Henry Meds: $297
Neither ShedRx nor Skinny Rx is the cheapest option in the category. Both sit below the upper end of the flat-rate cluster. The patient who knows she'll stick it out for six months should compare ShedRx's $249 against the field. The patient who wants escape velocity (the ability to cancel after month two without penalty) should compare month-to-month rates, where ShedRx at $279 and Skinny Rx starting at $269 are within spitting distance of each other.
The Clinical Model: Efficient, Not Thorough
Both providers operate asynchronous-first. The initial visit is a questionnaire, not a conversation. A licensed clinician reviews it and either writes the prescription or asks follow-up questions through the platform. Video is available on request in both cases, but it's not standard.
Here's where I'd push back on both of them: neither provider universally requires baseline labs before starting therapy. Both recommend labs and can arrange lab orders in some cases, but patients should not assume bloodwork will be obtained automatically. If you're starting compounded semaglutide, get baseline TSH, A1C, and a basic metabolic panel before your first injection. This isn't optional due diligence; it's minimum clinical hygiene. Any provider that doesn't insist on it is optimizing for speed over safety, even if the individual risk is low.
Dose escalation follows standard schedules unless the clinician adjusts. Both allow patients to message the clinical team about side effects or dose-hold requests. Response times vary.
The honest assessment: these platforms work well for patients who want a low-friction medication-delivery experience and are comfortable managing their own health data. If you want a clinician who knows your name and calls you back, you're looking at a different tier of provider entirely (think Mochi Health's clinician-network model or a clinician-led practice like Lavender Sky Health).
Sourcing and Regulatory Standing
Both providers use 503A pharmacy partners. Neither publicly names its pharmacy on consumer-facing pages, though both have historically disclosed pharmacy relationships on request after enrollment. Both have transitioned to personalization formulations following the FDA's February 2025 shortage resolution, consistent with the 503A patient-specific clinical-need standard.
Neither ShedRx nor Skinny Rx has been named as a defendant in the Novo Nordisk civil litigation, and neither has been the subject of an FDA warning letter. The regulatory profile for both is comparable to other asynchronous-first competitors in good standing.
Patients should ask which specific additive is used in their personalization preparation. This is the kind of question that separates an informed consumer from a passive one.
How They Stack Up Against HealthRX
For patients also considering HealthRX: the structural similarities across all three are significant. All are flat-rate or near-flat-rate, all are asynchronous-first, all use 503A pharmacy partners, and none have been named in Novo Nordisk litigation or subject to FDA enforcement actions. HealthRX is LegitScript-certified; Skinny Rx's certification status should be verified at the time of your evaluation.
On price, HealthRX at $179.99 to $279.99 flat-rate sits at the lower end of the cluster. ShedRx's six-month rate at $249 is competitive. Skinny Rx's $269 to $299 lands in the middle to upper range.
A patient choosing purely on price will typically find HealthRX or ShedRx's six-month rate to be the lowest options. A patient choosing on flexibility will prefer the month-to-month structures of HealthRX, Skinny Rx, or ShedRx's monthly tier over the six-month commitment.
My opinionated take: if you're a first-time GLP-1 patient and you're not sure you'll tolerate semaglutide well enough to stay on it for six months, locking into a commitment discount is like buying a gym's annual pass in January. It feels rational in the moment, and the math only works if your behavior doesn't change.
What to Ask Before You Sign Up
These questions apply to either provider. Print them out or copy them into your notes app before you go through intake:
Which 503A pharmacy will fill my prescription, and in which state is it licensed?
What is the exact formulation of the compounded preparation?
What is the response-time standard for clinical questions, and are clinical messages included in the monthly fee?
What is the protocol if I have side effects and want to hold or step down the dose?
If I sign up for a multi-month plan and want to cancel, what am I committed to financially?
What baseline labs are recommended, and can the provider order them?
Frequently Asked Questions
Is ShedRx semaglutide the same as brand-name Ozempic or Wegovy? No. ShedRx dispenses compounded semaglutide prepared by 503A pharmacy partners. Compounded semaglutide is not FDA-approved and is a different product from brand-name Ozempic (Novo Nordisk) or Wegovy, though the active ingredient is semaglutide.
Is Skinny Rx cheaper than ShedRx? It depends on the comparison. ShedRx's six-month commitment rate ($249/month) is lower than Skinny Rx's lowest tier ($269/month). On a month-to-month basis, ShedRx at $279 and Skinny Rx at $269 to $299 overlap. Neither is categorically cheaper.
Do ShedRx or Skinny Rx require lab work? Neither universally requires baseline labs as a condition of starting therapy. Both recommend them. Patients should independently arrange baseline TSH, A1C, and basic metabolic panel testing before beginning treatment.
Are ShedRx and Skinny Rx available in all states? Both operate in most states but exclude a handful based on state-specific telehealth regulations. The excluded states change periodically, so check current availability on each provider's site.
Can I switch from ShedRx to Skinny Rx (or vice versa) mid-treatment? Yes, but you'll need to go through intake with the new provider. If you're on ShedRx's six-month plan, check cancellation terms before switching. Your dose history should be shared with the new clinician for continuity.
Have ShedRx or Skinny Rx been involved in any FDA enforcement actions? Neither has been the subject of an FDA warning letter on its compounded GLP-1 program, and neither has been named in the Novo Nordisk civil litigation, based on public court records reviewed in early 2026.
How do ShedRx and Skinny Rx compare to HealthRX on price? HealthRX's flat-rate pricing of $179.99 to $279.99 is at the lower end of the category. ShedRx's six-month rate ($249) is competitive. Skinny Rx's $269 to $299 sits in the middle to upper range. All three use flat-rate structures where the price does not escalate with dose increases.
Related Reading
- Hims compounded semaglutide review
- Henry Meds semaglutide review
- Eden semaglutide review
- Mochi Health semaglutide review
- Best compounded semaglutide telehealth providers 2026
- Compounded semaglutide pillar guide
Not FDA-approved. HealthRX is not a medical practice. Information on this site is for educational purposes and is not a substitute for individualized medical advice. Treatment decisions are made between you and a licensed clinician. Compounded semaglutide is dispensed by state-licensed 503A pharmacies under individual prescriptions for clinically documented patient-specific need. Pricing and program terms for ShedRx and Skinny Rx are based on public information available in early 2026 and are subject to change. References: SUSTAIN program; STEP-1 (Wilding et al., NEJM 2021); STEP-3 (Wadden et al., JAMA 2021); STEP-4 (Rubino et al., JAMA 2021); SELECT (Lincoff et al., NEJM 2023); FDA Drug Shortage status update, February 2025.